Streetbeat News

Revenues

BTOG

Bit Origin has announced a collaboration with Aethir, a leading distributed GPU cloud provider. Aethir has secured nearly $150 million in funding and completed the generation of its $ATH token. The strategic partnership aims to enhance AI and crypto capabilities, with Bit Origin deploying Aethir devices in Singapore and Malaysia, driving growth for both companies.

Portfolio Pulse from Benzinga Newsdesk

June 26, 2024 | 1:18 pm

GDRX

GoodRx has launched a Prescription Cost Tracker to tackle issues of prescription affordability and price transparency. The tool highlights high medication costs, reduced insurance coverage, and increased friction as key factors. Consumers paid $21 billion out-of-pocket in 2024, averaging $16.26 per prescription.

Portfolio Pulse from Benzinga Newsdesk

June 26, 2024 | 1:17 pm

CMTL

Comtech has been awarded a contract to deliver Next Generation 9-1-1 services for the North Central Texas Emergency Communications District. The contract includes a five-year base award with three two-year options, totaling up to $30 million.

Portfolio Pulse from Benzinga Newsdesk

June 26, 2024 | 1:16 pm

KDLY

KindlyMD, Inc. (NASDAQ: KDLY) has successfully registered on SAM.gov and submitted its first grant application for the USDA Rural Utilities Service Distance Learning and Telemedicine Grant Program. This registration opens up numerous federal funding opportunities for the company.

Portfolio Pulse from Benzinga Newsdesk

June 26, 2024 | 1:11 pm

UGRO

urban-gro has signed approximately $12 million in new contracts within the cannabis sector during Q2.

Portfolio Pulse from Benzinga Newsdesk

June 26, 2024 | 1:10 pm

UGRO

urban-gro, Inc. (NASDAQ:UGRO) has signed new contracts worth approximately $12 million in the cannabis sector. The contracts include engineering, architecture, design services, equipment procurement, and construction management. The majority of the revenue is expected to be recognized by the end of Q3 2024.

Portfolio Pulse from Benzinga Newsdesk

June 26, 2024 | 1:10 pm

NRBO

NeuroBo Pharmaceuticals has dosed the first patient in the MAD Part 2 of its Phase 1 trial for DA-1726, an obesity treatment. Top-line data for Part 1 is expected in Q3 2024, and for Part 2 in Q1 2025. A planned Part 3 will assess weight loss at 24 weeks. The company has secured $70M in financing to fund ongoing clinical development.

Portfolio Pulse from Benzinga Newsdesk

June 26, 2024 | 1:08 pm

AMZN

CHGG

Chegg has selected Amazon Web Services (AWS) as its preferred cloud provider to enhance its AI-powered learning solutions. This five-year agreement aims to leverage AWS's advanced AI capabilities to improve personalized learning experiences for students globally.

Portfolio Pulse from Benzinga Newsdesk

June 26, 2024 | 1:07 pm

VVI

Viad Corp (VVI) is set to expand its Pursuit collection with the acquisition of Jasper SkyTram for $18 million. The acquisition is expected to add $4 million in revenue, with a total payment of C$25 million.

Portfolio Pulse from Benzinga Newsdesk

June 26, 2024 | 1:04 pm

GIS

General Mills (NYSE: GIS) reported disappointing Q4 FY24 revenue, leading to a 4.97% drop in its stock price. The company saw a 6.3% decline in sales year-on-year, missing analyst estimates. Despite a slight beat in adjusted EPS, the outlook for FY25 remains tepid with minimal expected growth.

Portfolio Pulse from Shivani Kumaresan

June 26, 2024 | 1:04 pm